Baxter International Inc has supply contracts with five countries, including the United Kingdom, Ireland and New Zealand.
The vaccine is made using a cell culture process, which is designed to be faster than traditional vaccine production methods, where virus samples must be put into specially raised chicken eggs to grow.
Several other companies are using conventional methods to develop H1N1 vaccines.
The Baxter vaccine will be sold under the brand name Celvapan.
Copyright © 2009 Radio New Zealand
- Vaccines as Biological Weapons? Live Avian Flu Virus Placed in Baxter Vaccine Materials Sent to 18 Countries
- Baxter Sent Bird Flu Virus to European Labs by Error (Update2)